Pacific Biosciences of California PACB Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's contract liabilities, non-current?
- Pacific Biosciences of California (PACB) reported contract liabilities, non-current of $3.55M in Q1 2026.
- How has Pacific Biosciences of California's contract liabilities, non-current changed year-over-year?
- Pacific Biosciences of California's contract liabilities, non-current decreased by 39.3% year-over-year, from $5.86M to $3.55M.
- What is the long-term trend for Pacific Biosciences of California's contract liabilities, non-current?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's contract liabilities, non-current has grown at a 20.2% compound annual growth rate (CAGR), from $1.57M to $3.93M.